THE EVOLUTION OF DIGITAL THERAPEUTICS (DTx) IN MENTAL HEALTH CARE: A SYSTEMATIC REVIEW OF SOCIAL IMPACT, ETHICAL CHALLENGES, AND PATIENT ENGAGEMENT
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.5192Keywords:
Digital Therapeutics, Mental Health, AI Ethics, Patient Engagement, Digital Health Equity, Socio-Technical SystemsAbstract
Background: The global landscape of mental health care has undergone a fundamental transformation driven by the emergence of Digital Therapeutics (DTx). These software-driven, evidence-based interventions are designed to deliver high-quality psychological support directly to the user. As traditional healthcare infrastructures face unprecedented strain and accessibility crises, DTx has transitioned from a niche supplementary tool to a cornerstone of modern digital psychiatry, redefining how clinical outcomes are achieved and measured in the digital age.
Objective: This systematic review critically evaluates the rapid evolution of the DTx sector between 2020 and 2026. The primary objective is to analyze three pivotal dimensions: the broader social implications of digital health democratization, the shifting ethical complexities introduced by the integration of Generative Artificial Intelligence (GenAI), and the persistent socio-technical barriers that hinder long-term patient adherence and therapeutic efficacy.
Methodology: Adhering to the PRISMA 2020 guidelines, a comprehensive systematic search was executed across PubMed, Scopus, and Web of Science. The synthesis included twenty-five high-impact studies focused on digital psychiatry, socio-technical frameworks, and algorithmic ethics. The analysis encompassed peer-reviewed literature regarding clinical validation processes, global regulatory shifts (such as the German DiGA market), and the principles of user-centered design (Abbas et al., 2025; Jiang et al., 2025; Gensorowsky et al., 2024).
Results: Findings reveal that while DTx offers a viable pathway for expanding care (Carlbring et al., 2018), significant "digital divides" persist. Socioeconomic status and digital literacy remain primary gatekeepers, preventing equitable distribution among marginalized and socioeconomically disadvantaged populations (Divatia et al., 2026; Hengst et al., 2023; Piers et al., 2023). Ethical challenges have evolved from basic data privacy toward sophisticated debates on algorithmic bias, the "black box" nature of AI diagnostics, and the critical necessity for "human-in-the-loop" oversight to mitigate clinical risks (Rahsepar Meadi et al., 2025; Shakeel et al., 2025). Furthermore, patient attrition remains the "Achilles heel" of digital interventions (Nwosu et al., 2022). Sustainable engagement is now increasingly linked to the implementation of "precision engagement" frameworks and the successful cultivation of a digital therapeutic alliance (Eiselt et al., 2025; Smith et al., 2025).
Conclusion: The evolution of DTx from 2020 to 2026 necessitates a paradigm shift toward a hybrid socio-technical ecosystem. Future success in the next decade will depend on moving beyond isolated clinical efficacy toward implementation strategies that are radically inclusive, ethically grounded, and designed for deep, human-centric engagement. Addressing the intersection of AI ethics and social equity is no longer optional but a requirement for the next generation of digital mental health care.
References
Abbas, S. R., Seol, H., Abbas, Z., & Lee, S. W. (2025). Exploring the role of artificial intelligence in smart healthcare: A capability and function-oriented review. Healthcare, 13(14), 1642. https://doi.org/10.3390/healthcare13141642
Ali, M., Ali, S., Abbas, Q., Abbas, Z., & Lee, S. W. (2025). Artificial intelligence for mental health: A narrative review of applications, challenges, and future directions in digital health. Digital Health, 11. https://doi.org/10.1177/20552076251395548
Calderone, A., Latella, D., & Fauci, E. L. (2025). Mind meets machine: A narrative review of artificial intelligence role in clinical psychology practice. Clinical Psychology & Psychotherapy, 32(6), e2984. https://doi.org/10.1002/cpp.70191
Campellone, T. R., Flom, M., & Montgomery, R. M. (2025). Safety and user experience of a generative artificial intelligence digital mental health intervention: Exploratory randomized controlled trial. Journal of Medical Internet Research, 27, e65432. https://doi.org/10.2196/67365
Carlbring, P., Andersson, G., Cuijpers, P., Riper, H., & Hedman-Lagerlöf, E. (2018). Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: An updated systematic review and meta-analysis. Cognitive Behaviour Therapy, 47(1), 1–18. https://doi.org/10.1080/16506073.2017.1401115
Divatia, S., Foster, T., Cui, S., Tapiavala, V., & Fortuna, K. L. (2026). Accessibility and equity considerations in the clinical validation of prescription digital therapeutics: A scoping review. mHealth, 12, 12. https://doi.org/10.21037/mhealth-25-12
Eiselt, A. K., Kirkendall, S., Xiong, E., & Langner, D. (2025). Achieving clinically meaningful outcomes in digital health: A six-step, cyclical precision engagement framework (ENGAGE). Frontiers in Digital Health, 7, 1713334. https://doi.org/10.3389/fdgth.2025.1713334
Fanta, G. B., & Pretorius, L. (2023). Sociotechnical factors of sustainable digital health systems: A system dynamics model. Health Policy and Technology, 12(1), 100729. https://doi.org/10.1016/j.hlpt.2023.100729
Friis-Healy, E. A., Nagy, G. A., & Kollins, S. H. (2021). It is time to REACT: Opportunities for digital mental health apps to reduce mental health disparities in racially and ethnically minoritized groups. JMIR Mental Health, 8(1), e25456. https://doi.org/10.2196/25456
Fürstenau, D., Gersch, M., & Schreiter, S. (2023). Digital therapeutics (DTx). Business & Information Systems Engineering, 65, 349–360. https://doi.org/10.1007/s12599-023-00804-z
Gensorowsky, D., Diekmannshemke, J., Witte, J., Rohn, I., & Schneider, U. (2024). PT23 The evolving German DiGA market: Insights from a claims data analysis. Value in Health, 27(12), S352. https://doi.org/10.1016/j.jval.2024.10.3825
Graham, S., Depp, C., Lee, E. E., Nebeker, C., Tu, X., Kim, H. C., & Jeste, D. V. (2019). Artificial intelligence for mental health and mental illnesses: An overview. Current Psychiatry Reports, 21(11), 116. https://doi.org/10.1007/s11920-019-1094-x
Hengst, T. M., Lechner, L., Dohmen, D., & Bolman, C. A. (2023). The facilitators and barriers of mHealth adoption and use among people with a low socio-economic position: A scoping review. Digital Health, 9. https://doi.org/10.1177/20552076231198702
Hosono, T., Niwa, Y., & Kondoh, M. (2024). Comparison of product features and clinical trial designs for the DTx products with the indication of insomnia authorized by regulatory authorities. Therapeutic Innovation & Regulatory Science, 58(6), 1138–1147. https://doi.org/10.1007/s43441-024-00684-9
Jiang, N., Yu, X., Yang, Y., Li, G., He, C., Wang, M. P., ... & Rao, K. (2025). Digital therapeutics in China: Comprehensive review. Journal of Medical Internet Research, 27, e70955. https://doi.org/10.2196/70955
Kuhn, E., Saleem, M., Klein, T., Köhler, C., Fuhr, D. C., Lahutina, S., ... & Böge, K. (2024). Interdisciplinary perspectives on digital technologies for global mental health. PLOS Global Public Health, 4(2), e0002867. https://doi.org/10.1371/journal.pgph.0002867
Nwosu, A., Boardman, S., Husain, M. M., & Doraiswamy, P. M. (2022). Digital therapeutics for mental health: Is attrition the Achilles heel? Frontiers in Psychiatry, 13, 900615. https://doi.org/10.3389/fpsyt.2022.900615
Piers, R., Williams, J. M., & Sharpe, H. (2023). Can digital mental health interventions bridge the ‘digital divide’ for socioeconomically and digitally marginalised youth? A systematic review. Child and Adolescent Mental Health, 28(1), 90–104. https://doi.org/10.1111/camh.12620
Rahsepar Meadi, M., Sillekens, T., Metselaar, S., van Balkom, A., Bernstein, J., & Batelaan, N. (2025). Exploring the ethical challenges of conversational AI in mental health care: A scoping review. JMIR Mental Health, 12, e60432. https://doi.org/10.2196/60432
Seo, Y. C., Yong, S. Y., Choi, W. W., & Kim, S. H. (2024). Meta-analysis of studies on the effects of digital therapeutics. Journal of Personalized Medicine, 14(2), 157. https://doi.org/10.3390/jpm14020157
Shakeel, H. M., Antoniou, G., & Adamou, M. (2025). Integrating explainable AI with clinical features to enhance ADHD diagnostic understanding. Frontiers in Psychiatry, 16, 1706216. https://doi.org/10.3389/fpsyt.2025.1706216
Smith, K. A., Ward, T., Lambe, S., et al. (2025). Engagement and attrition in digital mental health: Current challenges and potential solutions. npj Digital Medicine, 8, 398. https://doi.org/10.1038/s41746-025-01778-w
Srivastava, A., & Goswami, A. K. (2026). Data protection and mental health privacy: Legal standards for AI-powered psychological assessment and identity crisis intervention. In Imposter syndrome and AI: Navigating human identity in the age of intelligent machines (pp. 105–122). IGI Global Scientific Publishing. https://doi.org/10.4018/979-8-3373-6618-0.ch006
Torous, J., & Topol, E. J. (2025). Assessing generative artificial intelligence for mental health. The Lancet, 406(10504), 683. https://doi.org/10.1016/S0140-6736(25)01237-1
Volpe, U., Ramalho, R., & Gaebel, W. (2025). Risks of digitalization in mental health care. Neuropsychiatrie. https://doi.org/10.1007/s40211-025-00551-5
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Alicja Maria Mitan, Weronika Napierała, Karolina Magda Leszczyńska, Jeremi Leon Jasiński, Anna Krzysztofik, Karolina Krawczyk, Kamila Teresa Kańska, Aleksandra Maria Tomaszewska, Maciej Tomasz Wieczorek, Karolina Julia Hak
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
